Conversely, others have found that IL-25 treatment can reduce subcutaneous tumour growth across a broad range of implanted cancer cell lines in immunodeficient mice [174], most likely through directly inducing apoptosis as shown in breast cancer cells [175]. The gene discussed is IL25; the disease is neoplasm.